Elevating the Site-Sponsor Experience: SaaS-Based Feasibility and Site Selection for Clinical Trials



Wednesday, January 26, 2022 at 11am EST Are your feasibility assessments repetitious and frustrating for everyone involved? See why sites are already saying they are “highly satisfied” with an all-new Feasibility module from IQVIA Technologies in this complimentary webinar.

Register free http://www.appliedclinicaltrialsonline.com/act_w/saas_site

Event overview:

Sponsors need a data-driven way to validate assumptions and make the right decisions throughout study planning, protocol design, country/site scenario planning, and site selection. Yet feasibility assessments are repetitious and frustrating for everyone involved when the data collected are not standardized nor made available across the sponsor enterprise to be leveraged for future studies.

In this webinar, you’ll learn how IQVIA Technologies (formerly DrugDev) is transforming clinical trial feasibility and site selection across the industry. The all-new SaaS-based Feasibility module of the IQVIA Investigator Site Portal centralizes and streamlines feasibility assessments with a data-first strategy that enables sponsors to build positive site experiences and long-term investigator relationships across indications. Join us to see why sites are already saying they are “highly satisfied” with the Feasibility module and its tech-adoption support.

3 Key Take-Aways

  • Learn how sponsors can now automate CDA acceptance to expedite survey responses, site-selection decisions, and the transition into activation
  • Understand how the centralization of feasibility-assessment data, documents, and communication can bring efficiency, transparency, and speed to sponsors and sites
  • See how features such as question banks, survey response pre-population, and integrated dashboards enhance site-sponsor relationships and promote technology adoption across global and local sponsor teams.


KK Rumrill
Sr. Director, General Manager, Digital Planning and Site Suites
IQVIA Technologies

KK Rumrill has more than 25 years’ experience in product development, customer support, and implementation services teams in clinical trials. She was a key leader in client operations at BBK Worldwide, driving growth in global patient recruitment, site engagement, and trial optimization. In 2013, KK moved to TrialNetworks, which was acquired by DrugDev and subsequently by IQVIA in 2017. She now leads several key product teams in IQVIA Technologies’ Orchestrated Clinical Trials platform.

Matthew Jones
Feasibility Lead
IQVIA Technologies

Matt leads the design and delivery of Feasibility, a module of the IQVIA Investigator Site Portal that provides a one-stop shop for site-sponsor collaboration from study start-up to close-out. Matt also manages the customer success team that delivers deployment and support services and collaborates with the product team to ensure that the voice of the customer is integrated into the roadmap.

Cara Woodruff
Product Management Director, Feasibility
IQVIA Technologies

Cara is responsible for understanding business need through the voice of the customer. She defines the Feasibility product vision and roadmaps, develops and executes Feasibility product strategy, and drives product release cycles. She also collaborates with the engineering,DevOps, UI/UX design, User Knowledge Center, and Feasibility Delivery teams to deliver high quality and high value solutions.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/saas_site

Related Content
© 2024 MJH Life Sciences

All rights reserved.